MiƱoza, Genevie M.
HRN: 26-26-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2024
CLINDAMYCIN 300MG (CAP)
11/26/2024
12/03/2024
PO
300mg
Q8 X 7 Days
S/P Completion Curettage
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes